EudraCT Number: 2005-004973-55 Sponsor Protocol Number: ANTIVORIFUNGOL Start Date: 2006-08-18
Sponsor Name: FUNDACION PETHEMA
Full Title: ESTRATEGIA DE MANEJO ANTIFUNGICO DEL PACIENTE ONCOHEMATOLOGICO NEUTROPENICO. EMPLEO DE VORICONAZOL COMO TRATAMIENTO ANTICIPADO.
Medical condition: Estrategia de manejo antifungico de amplio espectro del paciente oncohemtologico neutropencio. Voriconazol como tratamiento anticipado.
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-005604-14 Sponsor Protocol Number: AIFA TX Start Date: 2006-12-19
Sponsor Name: IST. DI RICERCHE FARMACOLOG. M. NEGRI
Full Title: A randomized, prospective, multicenter trial to compare the effect on chronic allograft nephropathy prevention of mycophenolate mofetil versus azathioprine as the sole immunosuppressive therapy f...
Medical condition: kidney transplant
Disease: Version SOC Term Classification Code Term Level
6.1 10023439 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2006-005626-24 Sponsor Protocol Number: 1247 Start Date: 2006-12-07
Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Full Title: PHASE II STUDY ON PEMETREXED IN ADVANCED AND/OR RECURRENT CERVICAL CANCER
Medical condition: advanced or metastatic cervical cancer
Disease: Version SOC Term Classification Code Term Level
6.1 10008342 PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Completed)
Trial results: (No results available)

EudraCT Number: 2005-005641-19 Sponsor Protocol Number: ENG K001 GF / EC 406 Start Date:
Sponsor Name: Takeda Pharma GmbH
Full Title: 3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients with Ut...
Medical condition: Uterine fibroids (Uterus myomatosus)
Disease: Version SOC Term Classification Code Term Level
8.0 10046784 LLT
Population Age: Adults Gender: Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-005645-19 Sponsor Protocol Number: 20051130 Start Date: 2007-09-12
Sponsor Name: Dept of ped hem/onc
Full Title: RCT of oral ibuprofen for procedural anxiety, distress and pain in children with cancer
Medical condition: Pain and anxiety relief before needle insertion in a subcutanously implanted iv port in children with cancer.
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-005664-88 Sponsor Protocol Number: HB996 Start Date: 2006-12-08
Sponsor Name: University of Oxford
Full Title: Prospective Study of Mycobacterium Tuberculosis Specific Cellular immune Responses in Iatrogenically Immunosuppressed Patients: those undergoing TNF-alpha blockade or Awaiting Renal Trasnplants: A ...
Medical condition: Renal failure and iatrogenic immunosuppression associated with solid organ transplantation or TNF alpha blockade in rheumatoid arthritis ICD 10 codes included: N18 Z94.0 M05 M06 M07 M45
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-003799-13 Sponsor Protocol Number: 25632 Start Date: 2005-02-03
Sponsor Name: Serono International SA
Full Title: A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.
Medical condition: Relapsing form of MS ; diagnosis of MS is in accordance with the McDonald criteria
Disease: Version SOC Term Classification Code Term Level
7.0 10028245 PT
Population Age: Adults Gender: Male, Female
Trial protocol: SE (Completed) LT (Completed) IE (Completed) DK (Completed) GB (Completed) ES (Ongoing)
Trial results: View results

EudraCT Number: 2004-003809-25 Sponsor Protocol Number: L-9134 Start Date: 2004-12-20
Sponsor Name: Sanofi-Synthelabo Co. Ltd.
Full Title: Comparison of the efficacy and tolerability of drotaverine 80 mg or ibuprofen 400 mg administered alone with their combination for the treatment of primary and secondary dysmenorrhea
Medical condition: A NO-SPA és az ibuprofen kombinációja elfogadott és Magyarországon gyakran használták a nőgyógyászati gyakorlatban sok évvel ezelőtt. A kombináció használatával kapcsolatos súlyos mellékhatásról ne...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: HU (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-003824-36 Sponsor Protocol Number: SATEME-08 Start Date: 2005-09-15
Sponsor Name: Fundació Institut Català de Farmacologia
Full Title: Randomized, double blind, parallel groups, placebo controlled pivotal clinical trial to asses preliminary efficacy and security of a sublingual Cannabis Standardized Extract (Sativex) added to refe...
Medical condition: Chemotherapy induced nausea and vomiting
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-001705-21 Sponsor Protocol Number: 030705 Start Date: 2007-04-05
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Full Title: Phase II study to evaluate hepatic function and clinical aspects in patients with severe hepatic cirrhosis treated with multiple cycle of stem cells mobilisation by G-CSF administration.
Medical condition: Hepatic cirrhosis with severe liver dysfunction
Disease: Version SOC Term Classification Code Term Level
6.1 10019663 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)